Skip to main content

Table 1 Baseline demographic data and STPI scores at screening and baseline (safety population)

From: Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study

  8 mg lidocaine + 2 mg CPC (n = 125) 1 mg lidocaine + 2 mg CPC (n = 125) Total (N = 250)
Age, years 32.1 ± 12.6 31.6 ± 11.6 31.8 ± 12.1
Gender, n (%)
 Male 58 (46.4) 58 (46.4) 116 (46.4)
Race, n (%)
 Caucasian 124 (99.2) 124 (99.2) 248 (99.2)
Weight, kg 76.9 ± 19.6 78.6 ± 21.4 77.7 ± 20.5
Height, cm 173.2 ± 10.0 173.5 ± 9.8 173.3 ± 9.9
BMI, kg/m2 25.5 ± 5.6 25.9 ± 5.9 25.7 ± 5.7
STPI at screening, mm 71.5 ± 7.0 71.2 ± 6.7 71.4 ± 6.8
STPI at baseline, mm 72.3 ± 6.9 72.2 ± 6.8 72.2 ± 6.8
  1. Data are expressed as mean ± standard deviation unless otherwise stated
  2. CPC cetylpyridinium chloride, BMI body mass index, STPI sore throat pain intensity